Refine by
Chronic Autoimmune Disease Equipment & Supplies
11 equipment items found
Manufactured by:Setpoint Medical Corporation based inValencia, CALIFORNIA (USA)
This pathway shows promise as an alternative, efficient treatment option for rheumatoid arthritis (RA), Crohn’s disease, and other chronic autoimmune diseases – that may reduce risk, lower cost and improve patient adherence to ...
Manufactured by:Cabaletta Bio, Inc. based inPhiladelphia, PENNSYLVANIA (USA)
DSG3/1-CAART is being developed to treat mucocutaneous pemphigus vulgaris (mcPV), a B cell-mediated autoimmune disease that causes blistering of the skin and mucous membranes. mcPV is caused by autoantibodies that attack the cell adhesion proteins DSG3 and DSG1. DSG3/1-CAART is designed to selectively target and kill the B cells that express the pathogenic autoantibodies while preserving the ...
Manufactured by:OSE Immunotherapeutics based inNantes, FRANCE
A humanized monoclonal antibody, is an antagonist of the alpha chain of the interleukine-7 receptor, CD127, present on T effector cells, thus down regulating the immune activity. Interleukin-7 (IL-7) is a cytokine that controls the proliferation, apoptosis and activation of CD4 and CD8 effector T-cells in ...
Manufactured by:Ichor Medical Systems, Inc. based inSan Diego, CALIFORNIA (USA)
Ichor® is dedicated to the clinical application and commercialization of electroporation-mediated nucleic acid delivery. Ichor’s proprietary TriGrid Delivery System uses electrical fields to significantly enhance nucleic acid delivery as compared to conventional ...
Manufactured by:Mulei (Wuhan) New Material Technology Co. Ltd based inWuhan, CHINA
Common Name: Levamisole (hydrochloride). CAS Number: 16595-80-5. Molecular Weight: 240.752. Boiling Point: 344.4°C at 760 mmHg. Molecular Formula: C11H13CIN2S. Melting Point: 226-231°C. Flash Point: ...
Manufactured by:Scopus BioPharma based inNew York, NEW YORK (USA)
We are developing MRI-1867, our licensed rationally designed, orally available, dual-action, hybrid, small molecule that is an inverse agonist of the CB1 receptor, as well as an inhibitor of the iNOS ...
Manufactured by:OSE Immunotherapeutics based inNantes, FRANCE
OSE-230 is an agonist antibody against ChemR23, also known as chemerin chemokine-like receptor 1 (CMKLR1), a G-protein coupled receptor (GPCR) expressed on myeloid immune cells known to modulate inflammation. Persistent inflammation is a characteristic feature of all chronic inflammatory or autoimmune diseases and if not controlled or resolved, ...
Manufactured by:Allergan Aesthetics based inIrvine, CALIFORNIA (USA)
Patients receiving breast implants have reported a variety of systemic symptoms, such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others. Individual patient risk for developing these symptoms has not been well established. Some patients report complete resolution of symptoms when the implants are removed ...
Manufactured by:DxTerity Diagnostics Inc. based inRancho Dominguez, CALIFORNIA (USA)
Autoimmune diseases need analysis tools that go beyond superficial symptoms to recognize the distinct immune system activity of each patient. Modular transcriptome repertoire analysis 1, also known as modular genomics, shows tremendous promise for improving the characterization of patients with autoimmune diseases such as Systemic Lupus Erythematosus (SLE)7, Multiple Sclerosis (MS), Inflammatory ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Infliximab prevents the interaction of TNF-α with TNF-α receptor (TNFR1 and TNFR2). Infliximab has the potential for autoimmune, chronic inflammatory diseases and diabetic neuropathy ...
Manufactured by:Cabaletta Bio, Inc. based inPhiladelphia, PENNSYLVANIA (USA)
Our lead product candidate, DSG3-CAART, is being developed to treat mucosal pemphigus vulgaris (mPV), a blistering skin disease that affects mucous membranes. mPV is caused by autoantibodies that attack the cell adhesion protein desmoglein 3, or DSG3. DSG3-CAART is designed to selectively target and kill the B cells that produce DSG3 antibodies while preserving the healthy B cells critical to ...